Proteomic analyses of different human tumour-derived chaperone-rich cell lysate (CRCL) anti-cancer vaccines reveal antigen content and strong similarities amongst the vaccines along with a basis for CRCL's unique structure: CRCL vaccine proteome leads to unique structure.

Mayer-Sonnenfeld, Tehila; Har-Noy, Michael; Lillehei, Kevin O; Graner, Michael W

Mayer-Sonnenfeld, Tehila; Har-Noy, Michael; Lillehei, Kevin O; Graner, Michael W.

Mayer-Sonnenfeld T; Immunovative Therapies Ltd, Jerusalem, Israel.

Int J Hyperthermia ; 29(6): 520-7, 2013 Sep.

Article en En | MEDLINE | ID: mdl-23734882

Asunto(s)

Antígenos de Neoplasias/metabolismo; Vacunas contra el Cáncer; Neoplasias/metabolismo; Proteoma; Anciano; Femenino; Humanos; Masculino; Persona de Mediana Edad; Chaperonas Moleculares/metabolismo; Neoplasias/inmunología; Proteómica

Texto completo

Imprimir

XML

PubMed Links

Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas contra el Cáncer / Proteoma / Antígenos de Neoplasias / Neoplasias Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Año: 2013 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Search on Google